<DOC>
	<DOCNO>NCT01359293</DOCNO>
	<brief_summary>The primary objective study compare effect paliperidone versus oral antipsychotic change brain parenchymal volume , number relapse , time relapse one-year period follow patient new onset schizophrenia .</brief_summary>
	<brief_title>Effects Paliperidone Palmitate Versus Oral Antipsychotics Clinical Outcomes MRI Measures</brief_title>
	<detailed_description>Subjects participate 1 year treatment 3 MRI scan six month interval . Side effect metabolic measure follow course study .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Paliperidone Palmitate</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>1 . Patients DSMIV diagnosis schizophrenia schizophreniform disorder 2 . Age range 1840 3 . Ability provide inform consent 4 . First episode ( first hospital admission ) recent onset ( five year since onset first psychotic symptom ) 1 . Substance dependence either currently month prior entry ( except caffeine nicotine ) 2 . Unstable medical condition 3 . Pregnant lactate woman 4 . Implanted pacemaker , medication pump , vagal stimulator , deep brain stimulator , TENS unit , ventriculoperitoneal shunt ( MR study ) . 5 . IQ less 70</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>